Taipei, Taiwan

Pei-Chia Chan


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pei-Chia Chan: Innovator in Drug Delivery Systems

Introduction

Pei-Chia Chan is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on dual targeting drug carriers. Her research focuses on enhancing the effectiveness of drug delivery to specific tumor cells, tissues, or organs.

Latest Patents

Pei-Chia Chan holds a patent for a dual targeting drug carrier and its applications. This innovative drug carrier comprises a first targeting molecule and a second targeting molecule, which can be peptides, proteins, or antibodies. These targeting molecules are designed to bind to specific receptors, proteins, or glycoproteins, allowing for precise recognition of tumor cells. The dual targeting drug carriers can also be conjugated with imaging agents, radioactive molecules, or nanoparticles to form a conjugate, enhancing their therapeutic potential. She has 1 patent to her name.

Career Highlights

Pei-Chia Chan is affiliated with National Yang Ming Chiao Tung University, where she conducts her research and contributes to the academic community. Her work has garnered attention for its potential to revolutionize cancer treatment through targeted drug delivery.

Collaborations

Pei-Chia Chan has collaborated with notable colleagues, including Cheng Allen Chang and Keng-Li Lan. These partnerships have further enriched her research and expanded the impact of her innovations in the field.

Conclusion

Pei-Chia Chan is a trailblazer in the development of dual targeting drug carriers, showcasing the potential of targeted therapies in medicine. Her contributions to the field are paving the way for more effective cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…